Delivery Order SPE2DB20D2104-SPE2DB25FMFDG

Award Date 12/31/24
Potential Completion Date 1/2/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMFDG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,351.26 firm fixed-price delivery order covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a performance period through January 2, 2025.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC enables efficient government procurement of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment, across multiple therapeutic areas.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, with no major subcontractors listed. This award demonstrates the company's role as a key vendor for federal healthcare programs, particularly within the Department of Defense and veterans' healthcare systems.

Generated 4/1/25, 3:50 PM